NCOA5
Nuclear receptor coactivator 5
Also known as: bA465L10.6, CIA, NCOA5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCD5
- Gene
- NCOA5
- Ensembl
- ENSG00000124160
- Chromosome
- 20
- Canonical length
- 579 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Actin filaments
OverviewNCBI Gene
This gene encodes a coregulator for the alpha and beta estrogen receptors and the orphan nuclear receptor NR1D2. The protein localizes to the nucleus, and is thought to have both coactivator and corepressor functions. Its interaction with nuclear receptors is independent of the AF2 domain on the receptors, which is known to regulate interaction with other coreceptors. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
579 residues, UniProt reviewed canonical sequence.
>Q9HCD5|NCOA5
1 MNTAPSRPSP TRRDPYGFGD SRDSRRDRSP IRGSPRREPR DGRNGRDARD SRDIRDPRDL
61 RDHRHSRDLR DHRDSRSVRD VRDVRDLRDF RDLRDSRDFR DQRDPMYDRY RDMRDSRDPM
121 YRREGSYDRY LRMDDYCRRK DDSYFDRYRD SFDGRGPPGP ESQSRAKERL KREERRREEL
181 YRQYFEEIQR RFDAERPVDC SVIVVNKQTK DYAESVGRKV RDLGMVVDLI FLNTEVSLSQ
241 ALEDVSRGGS PFAIVITQQH QIHRSCTVNI MFGTPQEHRN MPQADAMVLV ARNYERYKNE
301 CREKEREEIA RQAAKMADEA ILQERERGGP EEGVRGGHPP AIQSLINLLA DNRYLTAEET
361 DKIINYLRER KERLMRSSTD SLPGPISRQP LGATSGASLK TQPSSQPLQS GQVLPSATPT
421 PSAPPTSQQE LQAKILSLFN SGTVTANSSS ASPSVAAGNT PNQNFSTAAN SQPQQRSQAS
481 GNQPPSILGQ GGSAQNMGPR PGAPSQGLFG QPSSRLAPAS NMTSQRPVSS TGINFDNPSV
541 QKALDTLIQS GPALSHLVSQ TTAQMGQPQA PMGSYQRHYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCOA5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 30 nTPM
- ovary: 27 nTPM
- testis: 25 nTPM
- thymus: 25 nTPM
- cervix: 24 nTPM
- endometrium: 24 nTPM
Single-cell type
- microglia: 112 nCPM
- somatotrophs: 94 nCPM
- lactotrophs: 82 nCPM
- choroid plexus epithelial cells: 80 nCPM
- thymic myoid cells: 72 nCPM
- thyrotrophs: 66 nCPM
Immune cell
- plasmacytoid DC: 22 nTPM
- naive B-cell: 18 nTPM
- MAIT T-cell: 16 nTPM
- memory CD4 T-cell: 14 nTPM
- memory CD8 T-cell: 14 nTPM
- eosinophil: 13 nTPM
Brain region
- cerebellum: 32 nTPM
- cerebral cortex: 24 nTPM
- hypothalamus: 24 nTPM
- choroid plexus: 23 nTPM
- white matter: 23 nTPM
- basal ganglia: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCOA5.
Disease | ImmuneIEDB
Conditions an epitope on NCOA5 was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glucose homeostasis
- insulin receptor signaling pathway
- negative regulation of insulin receptor signaling pathway
- negative regulation of transcription by RNA polymerase II
- regulation of signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Anticodon-binding domain superfamily
- Nuclear receptor coactivator/corepressor
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCOA5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCOA5 as an antibody target. Whether an autoantibody or antibody against NCOA5 could matter depends on whether native NCOA5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCOA5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCOA5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...